July 15, 2014 — Micell Technologies Inc. announced the United States Patent and Trademark Office (USPTO) has issued a ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and Blood ...
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience ...
June 24, 2014 — OrbusNeich announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE ...
June 10, 2014 — Ariad Pharmaceuticals Inc. and Medinol Ltd. earlier this year initiated two registration trials of ...
June 3, 2014 — Strokes kill nearly 130,000 Americans every year, according to the Centers for Disease Control and ...
May 23, 2014 — Stentys presented final results from the APPOSITION IV study of its new self-apposing sirolimus-eluting ...
May 13, 2014 — Elixir Medical Corp. received European CE mark approval for its DESolve 100 Novolimus-eluting Bioresorbab ...
May 9, 2014 — InspireMD Inc. initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS ...
May 1, 2014 — Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary ...
April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the ...
April 8, 2014 — The Society for Cardiovascular Angiography & Interventions (SCAI) issued a list of five specific ...
April 4, 2014 — A new stent covered with biodegradable coating continues to show statistical equivalence to Japan’s ...